Partners Innovation Fund portfolio company and PHS licensee Denali
Therapeutics was selected for FierceBiotech’s 2015 highly competitive
Fierce 15.
Most Recent Posts:
The Medically Engineered Solutions in Healthcare (MESH) Incubator: A case study of innovation “push”
In an opinion piece for STAT, Marc Succi, MD, Clinician-in-Residence at Mass General Brigham Innovation, addresses the…